Fion L. Sung

956 total citations
14 papers, 817 citations indexed

About

Fion L. Sung is a scholar working on Cancer Research, Surgery and Molecular Biology. According to data from OpenAlex, Fion L. Sung has authored 14 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Fion L. Sung's work include Cancer, Hypoxia, and Metabolism (4 papers), Folate and B Vitamins Research (3 papers) and Liver Disease and Transplantation (2 papers). Fion L. Sung is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Folate and B Vitamins Research (3 papers) and Liver Disease and Transplantation (2 papers). Fion L. Sung collaborates with scholars based in Hong Kong, China and United Kingdom. Fion L. Sung's co-authors include O Karmin, Yaw L. Siow, Kathy K. W. Au-Yeung, Connie W. Woo, Guoping Wang, Anthony T.�C. Chan, Brigette Ma, Edwin P. Hui, Qian Tao and Ka‐Fai To and has published in prestigious journals such as Circulation Research, Clinical Cancer Research and Kidney International.

In The Last Decade

Fion L. Sung

13 papers receiving 799 citations

Peers

Fion L. Sung
Fion L. Sung
Citations per year, relative to Fion L. Sung Fion L. Sung (= 1×) peers Nobuhide Hayashi

Countries citing papers authored by Fion L. Sung

Since Specialization
Citations

This map shows the geographic impact of Fion L. Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fion L. Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fion L. Sung more than expected).

Fields of papers citing papers by Fion L. Sung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fion L. Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fion L. Sung. The network helps show where Fion L. Sung may publish in the future.

Co-authorship network of co-authors of Fion L. Sung

This figure shows the co-authorship network connecting the top 25 collaborators of Fion L. Sung. A scholar is included among the top collaborators of Fion L. Sung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fion L. Sung. Fion L. Sung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sung, Fion L., Yan Cui, Edwin P. Hui, et al.. (2014). Silencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma.. PubMed. 4(6). 789–800. 18 indexed citations
2.
Hong, Bo, Vivian Wai Yan Lui, Edwin P. Hui, et al.. (2009). Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation. Investigational New Drugs. 29(3). 401–410. 23 indexed citations
3.
Ma, Brigette, Fion L. Sung, Qian Tao, et al.. (2009). The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines. Investigational New Drugs. 28(2). 107–114. 54 indexed citations
4.
Hui, Edwin P., Fion L. Sung, Brian Yu, et al.. (2008). Plasma Osteopontin, Hypoxia, and Response to Radiotherapy in Nasopharyngeal Cancer. Clinical Cancer Research. 14(21). 7080–7087. 33 indexed citations
5.
Sung, Fion L., Edwin P. Hui, Qian Tao, et al.. (2007). Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma. Cancer Letters. 253(1). 74–88. 46 indexed citations
6.
Sung, Fion L., et al.. (2006). Pharmacoproteomics Study of Cetuximab in Nasopharyngeal Carcinoma. Journal of Proteome Research. 5(12). 3260–3267. 18 indexed citations
7.
Sung, Fion L., Terence C. W. Poon, Edwin P. Hui, et al.. (2005). Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells.. PubMed. 19(1). 237–45. 63 indexed citations
8.
Au-Yeung, Kathy K. W., et al.. (2003). Hyperhomocysteinemia Activates Nuclear Factor-κB in Endothelial Cells via Oxidative Stress. Circulation Research. 94(1). 28–36. 161 indexed citations
9.
Sung, Fion L., et al.. (2002). Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-κB. Kidney International. 62(4). 1160–1170. 168 indexed citations
10.
Sung, Fion L., Tong Zhu, Kathy K. W. Au-Yeung, Yaw L. Siow, & O Karmin. (2002). Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney International. 62(4). 1160–1170. 10 indexed citations
11.
Wang, Guoping, Connie W. Woo, Fion L. Sung, Yaw L. Siow, & O Karmin. (2002). Increased Monocyte Adhesion to Aortic Endothelium in Rats With Hyperhomocysteinemia. Arteriosclerosis Thrombosis and Vascular Biology. 22(11). 1777–1783. 125 indexed citations
12.
Sung, Fion L., Yaw L. Siow, Guoping Wang, Edward G. Lynn, & O Karmin. (2001). Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis. Molecular and Cellular Biochemistry. 216(1-2). 121–128. 59 indexed citations
13.
Karmin, O, Filly Cheung, Fion L. Sung, Da‐Yuan Zhu, & Yaw L. Siow. (2000). Effect of Magnesium tanshinoate B on the production of nitric oxide in endothelial cells. Molecular and Cellular Biochemistry. 207(1-2). 35–39. 39 indexed citations
14.
Sung, Fion L., Yaw L. Siow, & K O. (2000). Homocysteine stimulates monocyte chemotaxis towards endothelial cells. Atherosclerosis. 151(1). 72–72.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026